CMS pick won’t commit to Medicare drug price negotiations

Published February 16, 2017 4:59pm ET



President Trump’s nominee to head the Centers for Medicare and Medicaid Services refused to endorse giving Medicare the power to negotiate drug prices, an idea the president has endorsed.

Seema Verma, who headed the creation of Indiana’s Medicaid Program, hedged when asked if she supported giving Medicare negotiating power during her confirmation hearing Thursday.

Already a print subscriber? Click here to login/register your account

Trusted reporting.Unlimited access.

Subscribe for full access to Washington Examiner coverage, expert political analysis, and subscriber-only journalism.

Get Unlimited Access

Already a member? Log in

Cancel anytime.